Medipharm Labs Corp (LABS)

Medipharm Labs Corp recorded one insider sale during the past ninety days. Director Christopher David Taves disposed of shares valued at approximately 13,259 CAD. This single transaction represents the entirety of recent activity, occurring amidst an 11.8% decline in stock price. No executive buying or selling occurred within this period.
Ticker: LABS Exchange: TOR


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Taves, Christopher David Director of Issuer Non-Executive Director
Transaction date
Sale
Price
32.03
Quantity 23,401 -6.4%
Value CA$2,756,615
1.7
Strachan, Keith Director of Issuer Non-Executive Director
Transaction date
Sale
Price
486.66
Quantity 51,618 -48.1%
Value CA$2,986,803
1.7
Strachan, Keith Director of Issuer Non-Executive Director
Transaction date
Sale
Price
58.75
Quantity 5,544 -31.1%
Value CA$3,451,024
0.8
Hunter, Gregory Edison Senior Officer of Issuer Officer
Transaction date
Sale
Price
0.06
Quantity 211,257 -28.2%
Value CA$12,675
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-12 2026-06-09 S Sale

Director of Issuer

Non-Executive Director
23,401 -6.4%
32.03
CA$2,756,615
23,401 -6.4% 32.03 CA$2,756,615
2023-08-23 2023-08-18 S Sale

Director of Issuer

Non-Executive Director
51,618 -48.1%
486.66
CA$2,986,803
51,618 -48.1% 486.66 CA$2,986,803
2023-06-30 2023-06-22 S Sale

Director of Issuer

Non-Executive Director
5,544 -31.1%
58.75
CA$3,451,024
5,544 -31.1% 58.75 CA$3,451,024
2023-06-27 2023-06-22 S Sale

Senior Officer of Issuer

Officer
211,257 -28.2%
0.06
CA$12,675
211,257 -28.2% 0.06 CA$12,675